| 规格 | 目录价格 | 上海 | 安徽 | 武汉 | 成都 | 北方 | 深圳 | 会员价格 | 数量 |
|---|---|---|---|---|---|---|---|---|---|
| 5g | ¥ ćƯĩƯƯ | 5 | 2 | -- | -- | -- | -- | ¥ ćƯĩƯƯ | - + |
| 1g | ¥ śǴĩƯƯ | 1 | 1 | -- | 1 | 1 | -- | ¥ śǴĩƯƯ | - + |
| 25g | ¥ ñǴĩƯƯ | 6 | 1 | 2 | 2 | 2 | ¥ ñǴĩƯƯ | - + | |
| 1g | ¥ łƂĞĩƯƯ | 4 | 8 | -- | 2 | -- | ¥ łƂĞĩƯƯ | - + | |
| 5g | ¥ ÿłśĩƯƯ | 2 | 1 | -- | 2 | 2 | 1 | ¥ ÿłśĩƯƯ | - + |
| 1kg | ¥ łƯśśĩƯƯ | 1 | -- | -- | 1 | 1 | 1 | ¥ łƯśśĩƯƯ | - + |
| 2.5kg | ¥ łƂĞǴĩƯƯ | -- | -- | -- | -- | -- | -- | ¥ łƂĞǴĩƯƯ | - + |
5.5
[1]. Atsushi Kambayashi, et al. Predicting the oral pharmacokinetic profiles of multiple-unit (pellet) dosage forms using a modeling and simulation approach coupled with biorelevant dissolution testing: case example diclofenac sodium. Eur J Pharm Biopharm. 214 Jul;87(2):26-4.
[2]. Hywel D Williams, et al. Lipid-based formulations solidified via adsorption onto the mesoporous carrier Neusilin? US2: effect of drug type and formulation composition on in vitro pharmaceutical performance. J Pharm Sci. 214 Jun;1(6):174-46.
[]. Hywel D Williams, et al. Toward the establishment of standardized in vitro tests for lipid-based formulations, part 4: proposing a new lipid formulation performance classification system. J Pharm Sci. 214 Aug;1(8):2441-55.
[4]. Joseph P O Shea, et al. Lipidic dispersion to reduce food dependent oral bioavailability of fenofibrate: In vitro, in vivo and in silico assessments. Eur J Pharm Biopharm. 215 Oct:96:27-16.
[5]. Karen Kleberg, et al. Sensing of triacylglycerol in the gut: different mechanisms for fatty acids and 2-monoacylglycerol. J Physiol. 215 Apr 15;59(8):297-19.

H2-H4
P264-P27-P27-P1+P1-P-P91-P51
GHS7,GHS9
![]()